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We investigated effects of the hydroalcoholic extract of Rosa сanina (dog rose) petals on 
behavior of rats in the elevated plus-maze (EPM) test; adult male Wistar rats weighing 
200-240 g were used. Oral everyday administration of the Rosa extract in three doses (150, 
300, and 450 mg/kg) was done for one week. Animal behavior in the EPM was videotaped for 
10 min, and conventional indices considered to be related to the anxiety level were scored. 
Introduction of the Rosa canina extract significantly increased the number of open arm 
entries in a dose-dependent manner and also increased the time of stay in the open arms at 
a high dose (450 mg/kg). At the same time, the number of closed arm entries interpreted as 
a correlate of the locomotion intensity did not differ from the control at all doses. Thus, the 
Rosa canina extract, when orally administered, demonstrates an anxiolytic profile in rats. 
Future investigations are essential for better understanding of the anxiolytic properties of 
the extract and neurobiological mechanisms of its action (probable interactions of the Rose 
extract active agents with neurotransmitter systems.
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INTRODUCTION
Anxiety is a natural psychophysiological reaction 
of animals and humans directed against known, 
unknown, and even imagined dangerous situations [1]. 
High levels of anxiety are characterized by a diffuse, 
unpleasant, and vague sense of apprehension. This 
state in humans is often accompanied by autonomic 
symptoms (headache, perspiration, palpitations, 
tightness in the chest, and mild stomach discomfort) 
[2]. High-anxiety states are among most important 
factors responsible for the development of pathological 
stresses. 
Benzodiazepines constitute the major class of 
pharmacological agents used for suppression of 
anxiety, and they have remained the most commonly 
prescribed treatment for anxiety in the respective cases 
[3]. Benzodiazepines, however, present a narrow safety 
margin between the anxiolytic effect and those causing 
unwanted side effects, and this situation has prompted 
many researchers to evaluate new compounds in 
the hope that other anxiolytic drugs will have less 
undesirable effects [4, 5]. 
Drugs derived from traditional plants may have 
possible therapeutic relevance in the treatment of 
anxiety. Research has been conducted to investigate 
natural anxiolytic agents in the search for alternative 
means [5, 6]. The effectiveness of a remedy obtained 
from Rosa damascene in the treatment of anxiety in 
animals has been described [7], and there is some 
evidence concerning the sedative effect of remedies 
from Rosa canina in humans [8, 9].
Rosa canina (Rosaceae), also known as dog rose, 
rose hip, or briar rose, is an extensively known prickly 
shrub (1-3 m high) with fragrant pink or white flowers. 
The respective genus is widely distributed in Europe, 
Asia, the Middle East, and North America [9-11]. This 
species has been evaluated for thousands of years for 
its food-related biological properties, and its multiple 
functional uses have been suggested. Teas and syrups 
made from pseudofruits of this plant are widely known 
as accessible valuable sources of vitamin C [12]; 
teas made from these fruits demonstrated laxative 
and diuretic effects [9]. Extracts of this plant were 
shown to possess a large amount of phytochemicals 
that include flavonoids and polyphenols having the 
potential to serve as antioxidants [6]. These extracts 
have also been extensively used as anti-inflammatory 
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agents, in particular in alternative treatment for 
osteoarthritis [13, 14]. 
On the basis of these considerations, we examined 
the anxiolytic effect of a hydroalcoholic extract 
prepared from Rosa canina flowers in experiments on 
rats using the elevated plus-maze (EPM) test. 
METHODS
Plant Material. The samples of flower petals of Rosa 
canina were collected in summer in the Ganjnameh 
Mountain, Hamadan, Iran. The flowers were picked 
in the morning and stored at a low temperature for 
further use. 
Preparation of the Extract. The flowers were air-
dried and milled. The milled flower material (180 g) 
was extracted with 80% ethanol. After the 3rd day, 
the extract was separated by filtering and subjected 
to evaporation and concentration using a rotary 
evaporator at 40°C. Then the concentrate obtained was 
dried at the laboratory temperature and, when used, 
dissolved in saline.
Animals. Male Wistar rats weighing 200-240 g were 
purchased from the Razi Institute, Tehran, Iran. During 
three days before the tests, animals were housed in 
groups of four per cage under a 12:12 dark/light cycle 
(lights on at 07:00 AM at 22 ± 2°C) with free access 
to food and water. Rats were randomly assigned to 
one control and three treated groups (n = 10 in each). 
All experiments were carried out under the same 
experimental environment in a soundproof room with 
controlled light conditions, between 11:00 AM and 
3:00 PM. Each animal was tested only once. 
Elevated Plus-Maze Test. The EPM design was 
standard and similar to that originally described [15]. 
In brief, the apparatus was composed of two open 
(50×10×0.25 cm) and two closed (50×10×30 cm) 
arms radiating from a central platform (10×10 cm). 
A slightly raised edge on the open arms (0.25 cm) 
provided an additional grip for the animals. The plus-
maze was elevated to a 50 cm height above the floor 
level by a single central support. 
Daily oral administration of the extract in three 
doses (150, 300, and 450 mg/kg) or saline was done for 
7 days. Animal behavior in the EPM was videotaped 
for 10 min and saved in the computer. The number 
of entries into and the times spent in each of the two 
types of arms were counted within a 10-min-long test 
period. The number of open-arm entries and open-arm 
time were used as indices correlating with the anxiety 
level, while the number of entries into the closed 
arms was believed to be a correlate of the intensity of 
spontaneous locomotion. A rat was considered to have 
entered the arm when all four paws were on the floor 
of the latter.
Statistical Analysis .  Numerical results are 
expressed as means ± s.e.m. The intergroup differences 
between the means were estimated by one-way 
analysis of variance (ANOVA) followed by the Tukey 
post-hoc test. In all cases, differences were considered 
significant if P < 0.05.
RESULTS
The effects of different doses of the Rosa canina 
extract on the time spent in the open arms are shown in 
Fig. 1. One-way ANOVA indicated that, compared to 
the control group, the animals treated with the extract 
spent more time in the open arms. The Tukey post-
hoc test showed that extract-treated groups spent more 
time in these arms at all doses (150 mg/kg, P < 0.05; 
300 and 450 mg/kg, P < 0.01). Normalized increments 
of the means related to the above doses of the extract 
were 53, 95, and 93%, respectively; thus, the effect 
can be considered to be dose-dependent.
The effects of different doses of the extract on the 
number of entries into the open arms are shown in 
Fig. 2. One-way ANOVA indicated that, compared to 
the control group, the extract, in general, increased this 
index. Results of the Tukey post-hoc test showed that 
the extract induced a significant increase in percentage 
of entries into the open arms only at the highest daily 
F i g. 1. Effects of the Rosa canina extract (150, 300, 450 mg/kg) 
on the time, sec, spent in the open arms of the elevated plus-maze 
within 10 min (n = 10 in each group). *P < 0.05, **P < 0.01 
compared to the control (saline) group. 
Р и с. 1. Впливи екстракту з квітів шипшини (150, 300 та 450 
мг/кг) на тривалість перебування щурів у відкритих рукавах 
піднятого лабіринту протягом 10 хв спостереження (n = 10 у 
кожній групі).
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dose of 450 mg/kg (P < 0.05, increment about 24%). 
At the same time, introductions of the extract in 150 
and 300 mg/kg daily doses induced practically no 
changes in the above-mentioned index.
The number of entries into the closed arms was 
not significantly different between the extract-treated 
and control groups. At the highest dose of the extract 
(450 mg/kg), the mean of the above index was slightly 
(by 13%, on average) smaller than in the control, but 
the difference was insignificant (Fig. 3). 
DISCUSSION
We investigated the behavioral effects of the 
hydroalcoholic extract from flower petals of Rosa 
canina. Our results demonstrated that peroral repeated 
introductions of the extract increased both normalized 
values of the number of entries and time spent in the 
open arms of the maze. In other words, the extract was 
able to produce a clear anxiolytic effect in rats after 
one-week-long oral administration. The effect of Rosa 
canina was not related to changes in general motor 
activity of the animals because the number of entries 
into the closed arms practically did not changed. An 
increase in the time and proportion of the entries into 
the open arms in the absence of changes in locomotor 
activity should be interpreted as a potent sign for a 
specific anxiolytic action of the extract [16, 17].
A number of animal tests are used for investigation 
of anxiolytic/anxiogenic effects of a variety of agents 
[18]. The EPM is a well-established animal test rather 
extensively used for estimation of changes in the 
anxiety level in small terrestrial rodents (e.g., rats and 
mice) [19]. These animals, in general, avoid spending 
time on open elevated surfaces. Changes in the number 
of entries into the open arms and time spent in these 
arms are interpreted as reliable correlates of changes 
in the level of anxiety in experimental animals. Thus, 
the EPM is considered a proven and reliable test for 
detecting both anxiolytic- and anxiogenic-like effects 
of different drugs [16, 20, 21]. 
The benzodiazepine family is known to be an 
effective group of pharmacological agents used 
for the treatment of anxiety disorders. At the 
same time, it is well known that benzodiazepines 
are capable of inducing certain rather significant 
side effects. Therefore, research directed toward 
finding new anxiolytic drugs with lesser adverse 
effects is considered highly expedient [3, 5, 22-24]. 
Various types of herbal medicines have been used as 
anxiolytics in different parts of the world [5]. 
Various plants have been used for medicinal 
purposes long before the beginning of recorded 
history [25], and their utilization in medicine is still 
extensively practiced around the world [26, 27]. 
Rosa canina L. has been used for the prevention and 
treatment of common cold, influenza-like infections, 
infectious diseases, fever, general exhaustion, gastric 
spasms, prevention of gastritis and gastric ulcers, 
diarrhea, gallstones and gallbladder discomforts, 
urinary tract diseases and discomforts, inflammatory 
disorder, arthritis, nephritis, rheumatism, gout, 
sciatica, diabetes, inadequate peripheral circulation, 
and lung ailments [12]. Using of Rosa canina fruits as 
a source of vitamin C has been mentioned above. 
Volatile oils are responsible for the unique and 
pleasant flavor of Rosa canina flowers [11]. Previous 
F i g. 2. Effects of the Rosa canina extract on the number of entries 
into the open arms of the elevated plus-maze. Other designations are 
similar to those in Fig. 1.
Р и с. 2. Впливи екстракту з квітів шипшини на кількість входів 
тварин у відкриті рукави піднятого лабіринту.
F i g. 3. Effects of the Rosa canina extract on the number of entries 
into the closed arms of the elevated plus-maze. Other designations 
are similar to those in Figs. 1 and 2.
Р и с. 3. Впливи екстракту з квітів шипшини на кількість входів 
тварин у закриті рукави піднятого лабіринту. 
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phytochemical studies of volatile oils of different Rosa 
species have led to identification of more than 400 
compounds, classified into several chemical groups. 
The latter include hydrocarbon, esters, alcohols, 
aromatic ethers, aldehydes, and norisoprenoids [28]. 
Phenols (eugenol and linalool) are among the major 
active components of Rosa canina [29, 30]. The dose-
dependent sedative effects of linalool (introduced 
i.p. or inhaled), including hypnotic and hypothermic 
effects, are manifested as an increase in sleeping time 
[31, 32]. 
In our study, the Rosa canina extract noticeably 
decreased the level of anxiety in rats. It should be 
mentioned that linalool inhalation was also shown to 
reduce anxiety [33]. As was reported, linalool prevents 
glutamate (i.e., the main excitatory neurotransmitter) 
from binding to its receptors in the rat neocortex [34]. 
Therefore, it seems that active phenol compounds of 
the Rosa extract work by inhibiting the excitatory 
neurotransmitter system rather than by potentiating the 
action of GABA, the main inhibitory neurotransmitter. 
The flavonoid rutin (quercetin-3-rutinoside) is a 
flavonol glycoside comprised of the flavonol quercetin 
and the disaccharide rutinose [35]. Rutin and quercetin 
are readily identified among flavonoids of Rosa canina 
[36]. Rutin is known to have anti-anxiety properties 
[37, 38] related to its action on the serotonin and 
GABA systems [37]. GABA is widely known to 
be involved in the etiology of anxiety considering 
the short-term effectiveness of diazepam, a GABA 
agonist, in relieving anxiety [39]. Quercetin also 
decreases the expression of corticotropin-releasing 
factor in the brain. The above factor is commonly 
implicated in high-anxiety states [40]. It is released 
from the hypothalamus, and consequent secretion 
of adrenocorticotropic hormone (ACTH) form the 
anterior pituitary and of glucocorticoids from the 
adrenal cortex is the major endocrine response to 
stress [38]. 
Thus, our results demonstrated that repeated oral 
administration of the Rosa flower extract exerts a clear 
anxiolytic effect in rats. The presence of flavonoids 
and linalool in the extract is probably the main factor 
responsible for manifestations of anxiolytic activity. 
Further studies would be necessary to evaluate the 
contribution of other substances present in the extract. 
The source of the extract is quite cheap and accessible. 
At the same time, it should be taken into account 
that significant anxiolytic effects of the extract were 
manifested only at rather high doses of the latter. 
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Р е з ю м е
Ми досліджували впливи водоспиртового екстракту з квітів 
шипшини (Rosa canina) на поведінку щурів у припіднятому 
хрестоподібному лабіринті; тестували дорослих самців (маса 
тіла 200–240 г). Екстракт із квітів шипшини вводили перорально 
(дози 150, 300 або 450 мг/кг) щоденно протягом одного тижня. 
Здійснювали відеозапис поведінки тварин у лабіринті протягом 
10 хв і підраховували стандартні показники, пов’язані з рівнем 
тривожності. Введення екстракту квітів шипшини зумовлювало 
вірогідне дозозалежне збільшення числа входжень до відкритих 
рукавів лабіринту та істотне збільшення тривалості перебу-
вання в цих рукавах (останнє лише в разі найбільшої дози, 
450 мг/кг). У той же час кількість заходжень до закритих рукавів 
лабіринту (корелят інтенсивності локомоції) не відрізнялася від 
контролю при всіх дозах. Отже, пероральне введення екстракту 
продемонструвало його анксіолітичний профіль в експеримен-
тах на щурах. Необхідні подальші дослідження анксіолітичних 
властивостей екстракту та нейробіологічних механізмів його 
дії (зокрема, можливої взаємодії активних агентів екстракту із 
нейротрансмітерними системами).
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